Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Archives of Biochemistry and Biophysics
|
July 19, 2021
GPNMB promotes the progression of diffuse large B cell lymphoma via YAP1-mediated activation of the Wnt/β-catenin signaling pathway
Zeyuan Wang, Xianting Ran, Siyu Qian, et al.
Aging
|
January 5, 2024
Clinical and therapeutical significances of the cluster and signature based on oxidative stress for osteosarcoma
Mengjie Ding, Xianting Ran, Siyu Qian, et al.
Journal of Cancer Research and Clinical Oncology
|
August 28, 2022
Real-world evidence of ABVD-like regimens compared with ABVD in classical Hodgkin lymphoma: a 10-year study from China
Qing Wen, Jingjing Ge, Yaxin Lei, et al.
Cancer Medicine
|
January 25, 2023
Decitabine combined with RDHAP regimen in relapsed/refractory diffuse large B cell lymphoma
Xiaoshuang Kong, Xudong Zhang, Mengjie Ding, et al.
Clinical and Translational Science
|
October 12, 2020
DDGP vs. SMILE in Relapsed/Refractory Extranodal Natural Killer/T-cell Lymphoma, Nasal Type: A Retrospective Study of 54 Patients
Xin Wang, Junxia Hu, Meng Dong, et al.
Journal of Translational Medicine
|
January 19, 2018
TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway
Linan Zhu, Xudong Zhang, Xiaorui Fu, et al.
Journal of Cellular Biochemistry
|
March 3, 2019
c-Myc mediated upregulation of long noncoding RNA SNHG12 regulates proliferation and drug sensitivity in natural killer/T-cell lymphoma
Linan Zhu, Xudong Zhang, Xiaorui Fu, et al.
Frontiers in Nutrition
|
October 24, 2022
The prognostic nutritional index, an independent predictor of overall survival for newly diagnosed follicular lymphoma in China
Jingjing Ge, Yaxin Lei, Qing Wen, et al.
Frontiers in Oncology
|
July 5, 2021
Combination of Decitabine and a Modified Regimen of Cisplatin, Cytarabine and Dexamethasone: A Potential Salvage Regimen for Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Treatment Failure
Junxia Hu, Xin Wang, Fei Chen, et al.
Cancer Biology & Medicine
|
October 11, 2021
Fotemustine-based therapy in combination with rituximab as a first-line induction chemotherapy followed by WBRT for newly diagnosed primary central nervous system lymphoma: a prospective phase II trial
Jingjing Wu, Fenghua Gao, Wenhua Wang, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Archives of Biochemistry and Biophysics
|
July 19, 2021
GPNMB promotes the progression of diffuse large B cell lymphoma via YAP1-mediated activation of the Wnt/β-catenin signaling pathway
Zeyuan Wang, Xianting Ran, Siyu Qian, et al.
Aging
|
January 5, 2024
Clinical and therapeutical significances of the cluster and signature based on oxidative stress for osteosarcoma
Mengjie Ding, Xianting Ran, Siyu Qian, et al.
Journal of Cancer Research and Clinical Oncology
|
August 28, 2022
Real-world evidence of ABVD-like regimens compared with ABVD in classical Hodgkin lymphoma: a 10-year study from China
Qing Wen, Jingjing Ge, Yaxin Lei, et al.
Cancer Medicine
|
January 25, 2023
Decitabine combined with RDHAP regimen in relapsed/refractory diffuse large B cell lymphoma
Xiaoshuang Kong, Xudong Zhang, Mengjie Ding, et al.
Clinical and Translational Science
|
October 12, 2020
DDGP vs. SMILE in Relapsed/Refractory Extranodal Natural Killer/T-cell Lymphoma, Nasal Type: A Retrospective Study of 54 Patients
Xin Wang, Junxia Hu, Meng Dong, et al.
Journal of Translational Medicine
|
January 19, 2018
TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway
Linan Zhu, Xudong Zhang, Xiaorui Fu, et al.
Journal of Cellular Biochemistry
|
March 3, 2019
c-Myc mediated upregulation of long noncoding RNA SNHG12 regulates proliferation and drug sensitivity in natural killer/T-cell lymphoma
Linan Zhu, Xudong Zhang, Xiaorui Fu, et al.
Frontiers in Nutrition
|
October 24, 2022
The prognostic nutritional index, an independent predictor of overall survival for newly diagnosed follicular lymphoma in China
Jingjing Ge, Yaxin Lei, Qing Wen, et al.
Frontiers in Oncology
|
July 5, 2021
Combination of Decitabine and a Modified Regimen of Cisplatin, Cytarabine and Dexamethasone: A Potential Salvage Regimen for Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Treatment Failure
Junxia Hu, Xin Wang, Fei Chen, et al.
Cancer Biology & Medicine
|
October 11, 2021
Fotemustine-based therapy in combination with rituximab as a first-line induction chemotherapy followed by WBRT for newly diagnosed primary central nervous system lymphoma: a prospective phase II trial
Jingjing Wu, Fenghua Gao, Wenhua Wang, et al.
Page
of 3